Elsevier announces free online medical information and clinical reference support for Japan earthquake relief efforts

- New Radiation Sickness Resource Pages Added to MD Consult and First Consult; Company Participating in National Library of Medicine Emergency Access Initiative

Elsevier (http://www.elsevier.com/), a world leader in health care and medical publishing and online solutions, today announced that following the devastating earthquake and tsunami that struck Japan on March 11, the company is providing free access to its primary online clinical reference tools - MD Consult and First Consult - to all IPs originating from Japan. Free access will be available through April, 2011. This effort is part of a new initiative to provide easily accessible focused resources in response to world events that present difficult medical challenges.

MD Consult (http://www.mdconsult.com/) is an authoritative combination of clinically relevant information to give medical professionals an answer to their clinical questions, stay abreast of recent developments, and educate patients, resulting in better patient care and improved outcomes. First Consult (http://www.firstconsult.com/) is Elsevier's point-of-care content that is integrated within MD Consult and leverages evidence-based medical information to deliver answers that are trusted, quick, and accessible.

MD Consult has also added a recommended resource topic page for Radiation Sickness (http://www.mdconsult.com/recommended-results/RADIATIONSICKNESS.lp), which is linked from http://www.mdconsult.com.

If access to a desktop computer is problematic, MD Consult has a mobile version, and First Consult has an iPhone/iPad app (s content in areas that have limited or no internet connectivity.

Emergency Access Initiative

Elsevier is also providing free online access to medical information for healthcare professionals in Japan through the Emergency Access Initiative (EAI)s earthquake in Haiti.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes